
ARA-290 (cibinetide) 11-residue reference peptide, 16 mg lyophilized at 98.8% HPLC purity.
ARA-290 is an erythropoietin-derived peptide used as a reference ligand in innate-repair-receptor research. Every PureLabs lot of ARA-290 is produced under GMP-aligned synthesis controls, assayed by an independent partner laboratory using reverse-phase HPLC with mass-spectrometric confirmation, and released only above the stated purity threshold of 98.8%. The certificate of analysis is lot-specific, carries the chromatogram and MS trace for the exact vial you receive, and stays archived under reference SEQ-1134 for as long as the batch exists.
Common laboratory questions about sourcing, purity, storage and shipping of ARA-290.
Current stock assays at 98.8% by reverse-phase HPLC, confirmed by mass spectrometry at an independent laboratory. Any lot testing below the threshold is rejected rather than sold.
Yes. A lot-specific certificate of analysis including the HPLC chromatogram and MS trace accompanies every ARA-290 order and remains retrievable under batch reference SEQ-1134.
Sealed lyophilized ARA-290 is stable at −20 °C for at least 24 months; once reconstituted, hold at 2–8 °C and use within about three weeks.
Orders confirmed before 15:00 UTC dispatch the same working day in insulated, tracked cold-chain packaging, subject to the import rules of the destination country.
No. PureLabs supplies this compound strictly as reference material for in-vitro and laboratory research. It is not a medicine and is not for human or veterinary consumption.